Mission BioCapital

Mission BioCapital is an early-stage life sciences venture capital firm founded in 2009, with offices in Cambridge, MA and San Francisco, CA. The firm invests in pre-seed through Series A life science companies, with a primary emphasis on therapeutics and opportunistic investments in diagnostics, medical devices, laboratory tools, and drug delivery. It is currently deploying its fifth fund ($275M, closed 2020). Beyond capital, the firm provides portfolio companies with access to shared lab space through partnerships with MBC BioLabs, LabCentral, and BioLabs, as well as mentorship and strategic support. The firm also runs the Platinum Program, an annual competition that awards up to $500,000 per winner alongside a guaranteed lab bench in one of 31 affiliated incubators across 22 cities in the U.S. and Europe, plus drug discovery services, legal advising, and scientific mentorship. The 2026 Platinum Program cycle has closed; applications are expected to reopen in Spring 2027. The firm has backed 60+ companies and counts Caribou Biosciences, Alector, and Mammoth Biosciences among its portfolio.